Emanuel Revici, MD: efforts to publish the clinical findings of a pioneer in lipid-based cancer therapy—Part 2

Townsend Letter for Doctors and Patients, Oct, 2004 by Marcus A. Cohen

"I have been asked by the Academy of Ophthalmology and Otolaryngology to organize a symposium on the treatment of headache to be given in New York City for a two day period between September nineteenth and twenty-fourth. This is to be in the teaching section, a two hour session being held on each of the two days. The members of the panel will discuss their treatment for ten minutes apiece during the first hour. The second hour will be devoted to the answering of questions from any auditor present. Your therapy is extremely new and unusual and I would be very happy indeed if you would agree to be a member of this panel."

21. Schmeck H M, Jr., Chemists study adrenal action. The New York Times, 9/19/59.

22. Letter from Fanny Holtzmann, esq., to S.A. Logan, First national City Bank, 4/13/55. The pertinent paragraph reads: "In the current issue of CANCER, official organ of the American Cancer Society (March, April 1955) there is an article by Dr. Marion Barclay et al, entitled "Lip-Proteins in Normal Women and in Women with Advanced Carcinoma of the Breast." The title carries the unusual footnote "The authors wish to thank Dr. Cornelius P. Rhodes for suggesting this problem and for his continuing support and interest." The article concludes that cancer patients have abormal Lip-Protein metabolism "which is associated with a severe defect in lipid metabolism. This is precisely the premise from which Dr. Revici set out on his biochemical explorations more than thirty years ago."

23. Letter from Edward M. Crane to Mrs. Sherman Pratt, 6/8/61.

Correspondence:

Marcus A. Cohen, HealthTrends

8 E. 96th St., 1C

New York, New York 10128 USA

212-427-0707 / Fax: 212-348-8288

marcanton1@juno.com